Irisin and adropin decrease in preobese or obese individuals with nonalcoholic fatty liver disease
Turkish Journal of Medical Sciences · 12.12.2025 · 55 (6) · 1513-1525
DOI: 10.55730/1300-0144.6110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 12.12.2025. Verfasst von Cuma Mertoğlu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Medicine, İnönü University, Malatya, Turkiye. Hauptthemen laut MEDLINE: Fibronectins, Obesity, Non-alcoholic Fatty Liver Disease, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: Nonalcoholic fatty liver disease (NAFLD) is a metabolic disease that is commonly observed in individuals with obesity. The present study investigates the irisin and adropin levels of sera in preobese or obese adults with NAFLD. Materials and methods: Included in the study were 89 patients who were categorized into four groups: Group 1: 25 normal-weight individuals without NAFLD (Control group); Group 2: 17 preobese or obese individuals without NAFLD; Group 3: 24 preobese or obese individuals with Grade 1 NAFLD; and Group 4: 23 preobese or obese individuals with Grade 2–3 NAFLD. The demographic details of all participants were recorded. Abdominal ultrasonography and anthropometric assessments were conducted. Serum adropin and irisin levels were determined using the Enzyme-Linked Immunosorbent Assay (ELISA) method.
Results
Serum adropin and irisin levels were lower in Groups 3 and 4 than in Group 1 (between the all groups; p = 0.006, p = 0.001, respectively), but were comparable between Groups 3 and 4. Furthermore, the atherogenic index of Group 1 was lower than that of Group 4 (p < 0.001). Among the hemogram parameters, the red cell distribution width value was higher in Group 3 than in Group 1 (p = 0.031).
Conclusion
Serum adropin and irisin levels decrease in the presence of NAFLD, regardless of disease severity, which may play a role in the development and exacerbation of NAFLD in preobese and obese individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry, Faculty of Medicine, İnönü University, Malatya, Turkiye.
- Department of Medical Biochemistry, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkiye.
- Department of Internal Diseases, Faculty of Medicine, Atatürk University, Erzurum, Turkiye.
- Department of Biostatistics, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkiye.
- Department of Biostatistics, Faculty of Medicine, Çukurova University, Adana, Turkiye.
ORCID-Profile: Cuma Mertoğlu, Yaprak Şule Örek, Bülent Albayrak, Yusuf Kemal Arslan, Abdulkadir Çoban
Zitieren
APA
Mertoğlu, C., Örek, Y. Ş., Albayrak, B., Arslan, Y. K., & Çoban, A. (2025). Irisin and adropin decrease in preobese or obese individuals with nonalcoholic fatty liver disease. Turkish Journal of Medical Sciences, 55(6), 1513-1525. https://doi.org/10.55730/1300-0144.6110
Vancouver
Mertoğlu C, Örek YŞ, Albayrak B, Arslan YK, Çoban A. Irisin and adropin decrease in preobese or obese individuals with nonalcoholic fatty liver disease. Turkish Journal of Medical Sciences. 2025;55(6):1513-1525. doi:10.55730/1300-0144.6110
BibTeX
@article{Mertolu2025,
author = {Mertoğlu, Cuma and Örek, Yaprak Şule and Albayrak, Bülent and Arslan, Yusuf Kemal and Çoban, Abdulkadir},
title = {Irisin and adropin decrease in preobese or obese individuals with nonalcoholic fatty liver disease},
journal = {Turkish Journal of Medical Sciences},
year = {2025},
volume = {55},
number = {6},
pages = {1513--1525},
doi = {10.55730/1300-0144.6110}
}
EUVIMED